Vivoryon Therapeutics N.V.

€0.62As of Sun 8 Nov 2026, 12:00 UTC
AMS:VVYHealthcare
Country Netherlands
PE (Fwd) •••
TSR 10Y CAGR (28.85%)
Div yield —
ROE (285.21%)
Biotechnology
Beta (5Y) 1.44
PE TTM —
TSR TTM (62.41%)
Mkt cap €18.30M
ROIC (173.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.791
27.98%
(49.41%)
Hold 11|4|3|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
14.82%
10.83%
14.24%
10.79%
Revenue€M
1.334
1.374
1.436
1.403
15.05%
13.19%
14.99%
7.62%
Peers (US$20.55M)
Cap (US$)
PE
11.33M
—
Capital
TTM
5Y
10Y
Leveragex
1.960
0.393
0.327
EBIT/Intx
0.847
0.086
0.097
Own earn%
2.02
(183.49)
(146.26)
Sh yield%
48.00
25.05
26.33
Owners
Insiders/Inst%
5.08
79.23
Short interest%
2.45
SBC / revenue%
4.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
25–33
$1 testx
0.7
Incr. ROIC%
1